# An Evidence Based Protocol for Oxytocin Administration in Vaginal Delivery

> **NCT02410655** · PHASE4 · WITHDRAWN · sponsor: **NYU Langone Health**

## Conditions studied

- Uterine Atony
- Postpartum Hemorrhage

## Interventions

- **DRUG:** Oxytocin
- **DRUG:** Oxytocin

## Key facts

- **NCT ID:** NCT02410655
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-11
- **Primary completion:** 2017-07-27
- **Final completion:** 2017-07-27
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Submission discarded. Study never enrolled subjects.
- **Last updated:** 2017-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02410655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02410655, "An Evidence Based Protocol for Oxytocin Administration in Vaginal Delivery". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02410655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*